IP Library Granted Patent US 10,725,030
Granted Patent B2
US 10,725,030 · App. 15/529,466 · Granted Jul 28, 2020

Method for determining analyte-ligand binding on a sensor surface

Inventor: Olof Karlsson (Uppsala, SE)
Assignee: GE HEALTHCARE BIO-SCIENCES AB
G01N33/54373G01N33/54393G01N33/558
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,725,030
App. No.
15/529,466
Granted
Jul 28, 2020
Kind
B2
Abstract

The present invention provides a method of assaying a sample solution for the presence of a first analyte comprising: (a) providing a sensor surface having a ligand immobilized thereto; (b) flowing the sample solution over the sensor surface; and (c) detecting the presence or absence of binding of the analyte to the ligand on the sensor surface; wherein the contact time between the sample solution and the immobilized ligand is less than 15 seconds.

Claims (27)

1. A method of assaying a plurality of sample solutions for the presence of analyte in the sample comprising:

(a) providing a sensor surface having a ligand immobilized thereto wherein the ligand has a ligand density on the sensor surface configured to allow binding of analyte in the plurality of samples;

(b) flowing a first sample solution over the sensor surface; and

(c) detecting the presence or absence of binding of a first analyte to the ligand on the sensor surface;

repeating steps (b) and (c) by flowing a subsequent sample solution that is the same or different than the first sample solution over the sensor surface to detect the presence or absence of binding between the ligand immobilized on the surface and a further analyte, the further analyte being the same or different than the first analyte, wherein the time between initiating the flowing of the first sample solution and flowing the second sample solution is less than forty seconds, and the contact time between the first sample solution and the immobilized ligand is less than 15 seconds wherein the contact time between the sample solution and the sensor surface having the ligand density is sufficient to allow binding between analyte in the plurality of samples and the ligand.

2. The method of claim 1 , wherein the contact time is less than 10 seconds.

3. The method of claim 1 , wherein the contact time is less than 5 seconds.

4. The method of claim 1 , wherein the contact time is less than 3 seconds.

5. The method of claim 1 , wherein the contact time is less than 2 seconds.

6. The method of claim 1 , wherein detection at the sensor surface is based on evanescent wave sensing.

7. The method of claim 1 , wherein detection at the sensor surface is based on surface plasmon resonance (SPR).

8. The method of claim 1 , wherein the further analyte is the same as the first analyte.

9. The method of claim 1 , wherein the further analyte is different to the first analyte.

10. The method of claim 1 , wherein steps (b) and (c) are repeated for a third sample solution.

11. The method of claim 1 , wherein steps (b) and (c) are repeated at least ten times to assay at least ten further solutions.

12. The method of claim 1 , wherein the cycle time is less than 15 seconds.

13. The method of claim 1 , wherein no regeneration step is carried out between initiating the flowing of at least one of the sample solutions over the sensor surface and initiating flowing of a next sequential sample solution over the sensor surface.

14. The method of claim 1 , wherein no washing step and/or no carry-over control injection step is carried out between initiating the flowing of at least one of the sample solutions over the sensor surface and initiating flowing of a next sequential sample solution over the sensor surface.

15. The method of claim 1 , wherein a ligand density on the sensor surface is up to 50000 RU.

16. The method of claim 15 , wherein the ligand density on the sensor surface is in a range 5000 RU to 15000 RU.

17. The method of claim 1 , wherein step (c) comprises determining the analyte concentration in the sample solution.

18. The method of claim 1 , wherein step (c) comprises determining the affinity of analyte to the ligand.

19. The method of claim 1 , comprising determining differences in analyte concentrations and/or analyte affinities between different sample solutions.

20. The method of claim 1 , wherein the ligand or analyte is an antibody or fragment thereof.

21. The method of claim 1 , wherein the method is used to screen antibodies.

22. The method of claim 1 , wherein the method is used as a fragment-based screen to identify non-specific binders or aggregators.

23. The method of claim 1 , wherein the method is used as a fragment-based screen to identify specific binders to the ligand.

Assignments (2)
CHANGE OF NAME Recorded Oct 8, 2020
From: GE HEALTHCARE BIO-SCIENCE AB
To: CYTIVA SWEDEN AB
Reel/Frame 054034/0144 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2017
From: KARLSSON, OLOF
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 042566/0012 →
Priority Claims (1)
SE 1451456 · Nov 28, 2014 · national
Continuity (1)
Related Publication 20170261502A1 · Sep 14, 2017
Cited By (1)
US 12,398,424